ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Ischemia"

  • 2018 American Transplant Congress

    Neuropeptide PACAP Protects Hepatocyte against Liver Ischemia/Reperfusion Injury by Promoting Yes-Associated Protein (YAP) Function

    Z. Xue, Y. Liu, C. Zhang, R. Busuttil, J. Kupiec-Weglinski, H. Ji.

    Dept of Surgery, The DumontUCLA Transplant Center, Los Angeles, CA.

    Background: Previously we have demonstrated that neuropeptide pituitary adenylate cyclase-activating polypeptides (PACAP) suppressed local inflammation, and protected liver against IRI by innervating the liver and…
  • 2018 American Transplant Congress

    p40 Homodimer Induced Proliferation of Endogenous Donor-Reactive Memory CD8 T Cells within High Risk Allografts Requires Memory CD8 T Cell Expression of CD122

    H. Tsuda, A. Valujskikh, R. Fairchild.

    Immunology, Cleveland Clinic, Cleveland, OH.

    Increasing the duration of cold ischemic storage (CIS) from 0.5 to 8 hrs prior to transplant induces the increased proliferation of endogenous donor-reactive CD4 and…
  • 2018 American Transplant Congress

    Phosphoproteomic Analysis of Mouse Hepatic Ischemia/Reperfusion Injury

    A. Zarrinpar,2 S. Duarte,1 Y. Lai.2

    1Surgery, University of California, Los Angeles, CA; 2Surgery, University of Florida, Gainesville, FL.

    Introduction: Hepatic ischemia/reperfusion injury (IRI) is a major risk factor for acute rejection and early graft dysfunction in liver transplantation. The large and complex landscape…
  • 2018 American Transplant Congress

    The First Series of Ischemia-Free Liver Transplantation in Human

    X. He,1 Z. Guo,1 S. Huang,1 Q. Zhao,1 Y. Tang,1 Z. Zhang,1 Z. Zhu,1 W. Ju,1 L. Yang,2 G. Chen.1

    1Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; 2Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

    BACKGROUND&AIMS: Ischemia and reperfusion injury (IRI) is known as an inevitable event leading to early and late graft failure. We have performed the first case…
  • 2018 American Transplant Congress

    Hyperglycemia Aggravates Hepatic Ischemia and Reperfusion Injury by Inhibiting Liver Resident Macrophage M2 Polarization via C/EBP-Homologous Protein-Mediated Endoplasmic Reticulum Stress

    Z. Rao, J. Sun, X. Pan, Z. Chen, H. Sun, P. Zhang, M. Gao, Z. Ding, C. Liu.

    Anesthesiology, First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

    Background:Aggravated liver ischemia and reperfusion (IR) injury has been observed in hyperglycemic hosts, but its underlying mechanism remains undefined. The aim of the study was…
  • 2018 American Transplant Congress

    Endothelin A Receptor (ETaR) siRNA Ameliorates Renal Ischemia Reperfusion Injury through Upregulating Expression of eNOS in Rats

    Y. Jia, L. Li, T. Zhu.

    Shanghai Key Labratory of Organ Transplantation, Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.

    Aims: To explore the protective effect of Endothelin A Receptor (ETaR) siRNA on renal ischemia reperfusion injury and its underlying mechanism.Methods: The model of unilateral…
  • 2018 American Transplant Congress

    Hypothermic Machine Perfusion Protects Rabbit Kidney Graft through Down Regulation SPP1-MMP7 Signaling Axis

    Q. Hu,1 Z. Zhong,1 S. Xue,1 W. Liang,1 J. Lan,1 J. Liang,1 Y. Xiong,1 Y. Wang,1 Q. Ye.1,2

    1Zhongnan Hospital of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China; 2The 3rd Xiangya Hospital of Central Sourth University, Changsha, China.

    Background: Multicenter studies have indicated that hypothermic machine perfusion(HMP) can be used to prolong cold ischemia time with high-quality preservation and allow utilization of kidney…
  • 2018 American Transplant Congress

    Extracellular Microvesicles from Liver Perfusate: microRNAs, Cellular Cross-Talk, and Early-Post Liver Transplant Outcomes

    A. Fernandez,1 O. Ingram,1 S. Bontha,1 U. Erdbruegger,2 L. Musante,2 V. Mas,1 D. Maluf.1

    1Surgery, UVA, Charlottesville; 2Nephrology Division, UVA, Charlottesville.

    Background: Ischemia reperfusion injury (IRI) is a multifactorial process that impact liver graft function. Donor quality plays a critical role during IRI and early graft…
  • 2018 American Transplant Congress

    Gr1– Macrophages Play Critical Roles in Liver Inflammation Resolution after IRI via Efferocytosis

    M. Ni,1,2 H. Wang,1,2 R. Busuttil,1 J. Kupiec-Weglinski,1 X. Wang,2 Y. Zhai.1

    1Surgery, David Geffen School of Medicine-UCLA, Los Angeles, CA; 2Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiansu, China.

    Inflammation resolution is an integral part of liver ischemia reperfusion injury (IRI), which affects not only the severity of tissue damage, but more importantly its…
  • 2018 American Transplant Congress

    The Novel Polymer Pro-Drug APP-103 Reduces I/R Injury and Improves Graft Function in a Pre-Clinical Renal Transplant Model

    K. Minami,1,3 H. Uehara,1,3 A. Elkhal,1,3 A. Weins,3 S. Bae,2,3 J. Reder,4 B. Houser,4 P. Kang,2,3 S. Tullius.1,3

    1Transplant Surgery Division, Department of Surgery, Brigham and Women's Hospital, Boston, MA; 2Beth Israel Deaconess Medical Center, Boston, MA; 3Harvard Medical School, Boston, MA; 4Celdara Medical, LLC, Lebanon, NH.

    Purpose: Ischemia-reperfusion injury (IRI) is the strongest non-HLA factor that augments allogenicity of transplanted organs. Damage subsequent to IRI is critically linked to an abundance…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 45
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences